Revolution Medicines, Inc.
USD190.51
-2.11 (-1.10%)
CEO
Mark A. Goldsmith
IPO Date
2020-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$189.53
Prev. Close
$192.62
Day Low
$189.02
Day High
$192.79
52W Low
$34.00
52W High
$192.80
Market Cap
$40.50B
Volume
0.34M
| 4,553 |
| $167.34 |
| 26 Jun 2026 | Anders Jack | Chief Financial Officer | S-Sale | Disposed | 9,496 | $168.20 |
| 26 Jun 2026 | Anders Jack | Chief Financial Officer | S-Sale | Disposed | 5,651 | $169.24 |
| 26 Jun 2026 | Anders Jack | Chief Financial Officer | S-Sale | Disposed | 300 | $170.32 |
| 26 Jun 2026 | Anders Jack | Chief Financial Officer | M-Exempt | Acquired | 20,000 | $18.56 |
| 23 Jun 2026 | Kim Lorence H. | director | A-Award | Acquired | 1,191 | $0.00 |
| 23 Jun 2026 | Kim Lorence H. | director | A-Award | Acquired | 3,127 | $162.99 |
| 23 Jun 2026 | Borisy Alexis | director | A-Award | Acquired | 1,191 | $0.00 |
| 23 Jun 2026 | Borisy Alexis | director | A-Award | Acquired | 3,127 | $162.99 |